Results 161 to 170 of about 22,554 (186)
TET3-overexpressing macrophages are a unifying pathogenic feature with therapeutic potential in chronic inflammatory diseases. [PDF]
Haji S, Ogawa Y.
europepmc +1 more source
Post-translational modifications of NLRP3: to prime or not to prime? [PDF]
Dufies O, Zanoni I.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The American Journal of Pathology, 2022
Idiopathic pulmonary fibrosis (IPF) is a dramatic disease without cure. The US Food and Drug Administration-approved drugs, pirfenidone and nintedanib, only slow disease progression. The clinical investigation of novel therapeutic approaches for IPF is an unmet clinical need. Nucleotide-binding oligomerization domain-like receptor or NOD-like receptors
Ruben M.L. Colunga Biancatelli +2 more
openaire +2 more sources
Idiopathic pulmonary fibrosis (IPF) is a dramatic disease without cure. The US Food and Drug Administration-approved drugs, pirfenidone and nintedanib, only slow disease progression. The clinical investigation of novel therapeutic approaches for IPF is an unmet clinical need. Nucleotide-binding oligomerization domain-like receptor or NOD-like receptors
Ruben M.L. Colunga Biancatelli +2 more
openaire +2 more sources
Bioorganic & Medicinal Chemistry Letters, 2020
Aberrant activation of NLRP3 inflammasome is present in a subset of acute and chronic inflammatory diseases. The NLRP3 inflammasome has been recognized as an attractive therapeutic target for developing novel and specific anti-inflammatory inhibitors. Cellular structure-activity relationship-guided optimization resulted in the identification of 4-oxo-2-
Yun, Chen +8 more
openaire +2 more sources
Aberrant activation of NLRP3 inflammasome is present in a subset of acute and chronic inflammatory diseases. The NLRP3 inflammasome has been recognized as an attractive therapeutic target for developing novel and specific anti-inflammatory inhibitors. Cellular structure-activity relationship-guided optimization resulted in the identification of 4-oxo-2-
Yun, Chen +8 more
openaire +2 more sources

